Abstract

Doug Muzyka, DuPont’s chief science and technology officer, says the company’s reorganization of R&D in advance of its merger with Dow Chemical does not mean an end to corporate research at DuPont....

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call